AI assistant
SIGMAROC PLC — Regulatory Filings 2021
Aug 31, 2021
7917_rns_2021-08-31_d5027112-a4e8-4b03-ba79-27f0b4af8906.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 2316K
SigmaRoc PLC
31 August 2021
31 August 2021
(EPIC: SRC / Market: AIM / Sector: Construction Materials)
SIGMAROC PLC
('SigmaRoc' or the 'Company')
Change of Registered Office and Investor Relations Appointment
SigmaRoc, the AIM quoted buy-and-build construction materials group, is pleased to announce that it has changed its registered office to Suite 1, 15 Ingestre Place, London, W1F 0DU with immediate effect.
As previously notified, Dean Masefield has stepped down from the board of directors and resumed the role that he previously held, Deputy Chief Financial Officer for the PPG, Channel Islands, South Wales and Benelux platforms. In addition, Dean has assumed the role of Head of Investor Relations.
For further information, please contact:
| SigmaRoc plc Max Vermorken |
Tel: +44 (0) 207 002 1080 |
| Strand Hanson Limited (Nominated and Financial Adviser) James Spinney / James Dance / Rob Patrick |
Tel: +44(0) 207 409 3494 |
| Liberum Capital (Co-Broker) Neil Patel / Jamie Richards / William Hall |
Tel: +44 (0) 203 100 2000 |
| Peel Hunt (Co-Broker) Mike Bell / Ed Allsopp |
Tel: +44 (0) 20 7418 8900 |
| Investor Relations Dean Masefield / Florian Werner |
Tel: +44 (0) 207 002 1080 [email protected] |
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CROWPUAWRUPGGUG